In focus · trending topic

Bempedoic Acid/Ezetimibe Combo

9 stories · following the connections

Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 3, 2018, 9:30 PM UTC

Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors

By Nasdaq OMXDec 14, 2017, 9:30 PM UTC

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

By Nasdaq OMXDec 1, 2017, 9:30 PM UTC

Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference

By Nasdaq OMXNov 9, 2017, 9:30 PM UTC

Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results

By Nasdaq OMXNov 7, 2017, 1:02 PM UTC

Esperion Announces Initiation of Pivotal Phase 3 Study for the Bempedoic Acid / Ezetimibe Combination Pill

By Nasdaq OMXNov 6, 2017, 9:30 PM UTC

Esperion to Host Analyst and Investor Day Event on October 17

By Nasdaq OMXOct 10, 2017, 12:31 PM UTC

Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2017 Financial Results

By Nasdaq OMXAug 8, 2017, 12:01 PM UTC